Cybin Inc. is a biopharmaceutical company in Toronto, Canada, specializing in psychedelic-based therapeutics. Their pipeline includes CYB003 for major depressive and alcohol use disorders, CYB004 for anxiety disorders, and CYB005 for neuroinflammation. They have also created EMBARK, a psychedelic-assisted psychotherapy.